-
Mashup Score: 2Identification of complement factor H variants that predispose to pre-eclampsia: A genetic and functional study - PubMed - 10 day(s) ago
These results suggest that complement dysregulation due to mutations in complement factor H is among the pathophysiological mechanisms underlying severe pre-eclampsia.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 35Understanding rare genetic variants within the terminal pathway of complement system in preeclampsia - 10 day(s) ago
Genes & Immunity – Understanding rare genetic variants within the terminal pathway of complement system in preeclampsia
Source: www.nature.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 202024 Mid-Career Women Faculty Leadership Development Seminar - 1 month(s) ago
I’m attending the AAMC’s 2024 Mid-Career Women Faculty Leadership Development Seminar! I’m looking forward to connecting with other women faculty, enhancing my leadership capabilities, and creating an actionable plan for my career progression. Check out the program.
Source: web.cvent.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 21Advancing IgAN Care: Exploring the Next Wave of Treatments - 2 month(s) ago
HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.
Source: www.hcplive.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 51Establishing the Future Direction of Clinical Outcomes in C3 Glomerulopathy: Perspectives From a Patient and a Physician - 2 month(s) ago
Complement 3 glomerulopathy (C3G) is an ultra-rare glomerulonephritis caused by dysregulation of the alternative complement pathway. C3G has an estimated incidence of 1–3 cases per million people in the United States. Diagnosing C3G based solely on clinical and laboratory features is challenging since it mimics several other glomerular diseases; therefore, diagnosis requires a kidney biopsy. In the absence of disease-modifying therapies and optimal patient management strategies, C3G poses a significant physical and emotional burden on patients and caregivers.
Source: www.kidneymedicinejournal.orgCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 41Evaluation for genetic disease in kidney transplant candidates: A practice resource - 2 month(s) ago
The increasing availability of clinically approved genetic tests for kidney disease has spurred the growth in the use of these tests in kidney transplant practice. Neither the testing options nor the patient population where this should be deployed has been defined and its value in kidney transplant evaluation has not been demonstrated. Transplant providers may not always be aware of the limitations of genetic testing and may need guidance on comprehending test results and providing counsel, as many centers do not have easy access to a renal genetic counselor or a clinical geneticist.
Source: www.amjtransplant.orgCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 6Mortality Risk Dropped for Living Kidney Donors Over the Past Decade - 5 month(s) ago
Deaths more common in male donors and those with history of hypertension
Source: www.medpagetoday.comCategories: General Medicine News, NephrologyTweet
The first in the series was published last year: https://t.co/v4IKYqdCEn